Advisory Services Network, LLC

Position in EXEL — Exelixis, Inc.

CIK 1573876 Atlanta, GA

Position in EXEL

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,118,559

-$144,207 QoQ

Shares Held

20,558

-30.2% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#329

of 751 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Advisory Services Network, LLC holds $28,927,722 across 25 Biotechnology names. EXEL ranks #8 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	51,566	$5,845,518
2	REGN	Regeneron Pharmaceuticals, Inc.	4,289	$2,674,357
3	VRTX	Vertex Pharmaceuticals Inc / Ma	5,141	$2,553,682
4	OCUL	Ocular Therapeutix, Inc	230,454	$2,263,058
5	ALNY	Alnylam Pharmaceuticals, Inc.	6,356	$1,913,344
6	ARWR	Arrowhead Pharmaceuticals, Inc.	17,371	$1,415,907
7	RPRX	Royalty Pharma plc	25,135	$1,409,315
8	EXEL	Exelixis, Inc. This page	20,558	$1,118,559

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,118,559	20,558	-30.2%	Shares	Other	2026-08-12
2026-03-31	$1,262,766	29,442	+28.3%	Shares	Sole	2026-05-15
2025-12-31	$1,005,547	22,942	-51.2%	Shares	Sole	2026-02-17
2025-09-30	$1,942,875	47,043	+15.6%	Shares	Sole	2025-11-18
2025-06-30	$1,793,967	40,698	+38.6%	Shares	Sole	2025-08-19
2025-03-31	$1,084,117	29,364	+432.2%	Shares	Sole	2025-05-15
2023-12-31	$132,352	5,517	+174.6%	Shares	Sole	2024-02-09
2023-03-31	$38,994	2,009	+5.2%	Shares	Sole	2023-05-17
2022-12-31	$30,620	1,909	-19.1%	Shares	Sole	2023-02-13
2021-06-30	$42,999	2,360	0.0%	Shares	Sole	2021-08-12
2020-12-31	$47,365	2,360	+164.0%	Shares	Sole	2021-02-09
2020-09-30	$21,858	894	+17.6%	Shares	Sole	2020-11-16
2020-03-31	$13,087	760	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.